Home buprenorphine/naloxone induction in primary care.

ABSTRACT:

Background

Buprenorphine can be used for the treatment of opioid dependence in primary care settings. National guidelines recommend directly observed initial dosing followed by multiple in-clinic visits during the induction week. We offered buprenorphine treatment at a public hospital primary care clinic using a home, unobserved induction protocol.

Methods

Participants were opioid-dependent adults eligible for office-based buprenorphine treatment. The initial physician visit included assessment, education, induction telephone support instructions, an illustrated home induction pamphlet, and a 1-week buprenorphine/naloxone prescription. Patients initiated dosing off-site at a later time. Follow-up with urine toxicology testing occurred at day 7 and thereafter at varying inter

SUBMITTER: Lee JD 

PROVIDER: S-EPMC2628995 | biostudies-literature | 2009 Feb

REPOSITORIES: biostudies-literature